A four-gene signature-derived risk score for glioblastoma: prospects for prognostic and response predictive analyses

摘要

ObjectiveGlioblastoma (GBM) is the most common primary malignant brain tumor regulated by numerous genes, with poor survival outcomes and unsatisfactory response to therapy. Therefore, a robust, multi-gene signature-derived model is required to predict the prognosis and treatment response in GBM.